Analyst Price Target is $14.85
▲ +21.04% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Hims & Hers Health in the last 3 months. The average price target is $14.85, with a high forecast of $20.00 and a low forecast of $10.00. The average price target represents a 21.04% upside from the last price of $12.27.
Current Consensus is
Moderate Buy
The current consensus among 13 contributing investment analysts is to moderate buy stock in Hims & Hers Health. This Moderate Buy consensus rating has held steady for over two years.
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
Read More
